Upcoming Meetings: RAPS meetings
This article was originally published in The Gray Sheet
RAPS meetings: Regulatory Affairs Professional Society schedules meeting on "Clinical Trials for Drugs, Devices and Biologics" Oct. 7-8 at the Sheraton City Centre Hotel in Washington, D.C. The meeting will address FDA's role in clinical trials, study design considerations, statistical approaches for data analysis, and how investigational review boards decide on study protocols. In addition, RAPS plans to hold a meeting on "Advertising, Labeling and Consumer Education" Oct. 28-29 at the Hyatt Regency in Bethesda, Maryland. Issues to be addressed include: direct-to-consumer advertising; promotion of off-label device and drug uses; promotion to managed care; and Internet advertising. For more information on either meeting, contact RAPS' education department at 301/770-2920 ext. 224/229...
You may also be interested in...
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.